CHCL Stock View

Cian Healthcare Ltd

icon 0.41 | 1.78
Market Cap ₹( Cr.)
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
Proj. Revenue ( Cr.)

Stock View

Last Updated On.

The average score for Cian Healthcare Ltd stands at 2 against 3, three months back.

Cian Healthcare Limited is an India-based company. The Company is engaged in the manufacturing and marketing of pharmaceutical products. It renders services for Third Party Pharmaceutical Manufacturing. The Company is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. It is also engaged in the business of manufacturing cosmetic products. The Company caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data

50 DMA(₹)
100 DMA(₹)
200 DMA(₹)
52 Weeks Range
15.05     41.10

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required